LDLR and familial hyperaldosteronism: In FH, LDL receptor (LDLR) deficiency (attributed to at least one of 1200 documented mutations3, 4) impedes receptor-mediated endocytosis of LDL, resulting in pathologically elevated serum LDL levels.